Molecular Data Inc.
MKDTY · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $8 | $13 | $9 | $4 |
| % Growth | -42.7% | 46.3% | 115.5% | – |
| Cost of Goods Sold | $8 | $13 | $9 | $4 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -0.1% | 0.8% | 0.9% | 1.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.4% | -1.4% | -2.6% | -2.2% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.3% | -1.5% | -2.8% | -2.6% |
| EPS | -42.4 | -27.71 | -33.2 | -14.06 |
| % Growth | -53% | 16.5% | -136.1% | – |
| EPS Diluted | -42.3 | -27.71 | -33.2 | -14.06 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.1% | -1.4% | -2.6% | -2.1% |